Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Laura L. Kiessling
Massachusetts Institute of Technology, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Quintessence Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This outside activity has a nexus with the investigator's research activities because the outside activity arises from and relies upon the academic expertise that qualifies this individual to participate in this PHS funded research activity. The combination of the investigator's significant financial interest in the outside activity and the nexus between the investigator's research corresponds to the definition of a FCOI and so requires management.
The Chemistry and Biology of Galactofuranose-Containing Glycans
NA
Filed on March 06, 2017.
Tell us what you know about Laura L. Kiessling's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Laura L. Kiessling”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Laura L. Kiessling | University of Wisconsin Madison | Conflict of Interest | Quintessence Biosciences | Value cannot be readily determined |
| Laura L. Kiessling | University of Wisconsin Madison | Conflict of Interest | Quintessence Biosciences | $5,000 - $9,999 |
| Laura L. Kiessling | Massachusetts Institute of Technology | Conflict of Interest | Hyrax Energy | Value cannot be readily determined |
| Laura L. Kiessling | University of Wisconsin Madison | Conflict of Interest | Quintessence Biosciences | $5,000 - $9,999 |
| Laura L. Kiessling | University of Wisconsin Madison | Conflict of Interest | Quintessence Biosciences | Value cannot be readily determined |
| Laura L. Kiessling | University of Wisconsin Madison | Conflict of Interest | Hyrax Energy | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.